MedDataX Logo

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

NCT ID: NCT00808067

Last Updated: 2014-06-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

5897 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purposes of this study are:

1. To evaluate the long-term safety of dabigatran etexilate
2. To assess the effect of a knowledge translation intervention on patient outcomes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

NCT00262600

Atrial Fibrillation Stroke
COMPLETED PHASE3

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

NCT04593043

Atrial Fibrillation
COMPLETED

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

NCT02864758

Atrial Fibrillation
COMPLETED

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

NCT01606995

Atrial Fibrillation
COMPLETED

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330

Thromboembolism
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dabigatran dose 1

dabigatran high dose twice daily

Group Type EXPERIMENTAL

dabigatran dose 1

Intervention Type DRUG

dabigatran high dose twice daily

dabigatran dose 2

dabigatran low dose twice daily

Group Type EXPERIMENTAL

dabigatran dose 2

Intervention Type DRUG

dabigatran low dose twice daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dabigatran dose 1

dabigatran high dose twice daily

Intervention Type DRUG

dabigatran dose 2

dabigatran low dose twice daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participation in RE-LY, requires long term anticoagulation, provides written informed consent

Exclusion Criteria

Permanent discontinuation of dabigatran during RE-LY
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

1160.71.1582 Boehringer Ingelheim Investigational Site

Seoul, , South Korea

Site Status

1160.71.0046 Boehringer Ingelheim Investigational Site

Birmingham, Alabama, United States

Site Status

1160.71.0057 Boehringer Ingelheim Investigational Site

Birmingham, Alabama, United States

Site Status

1160.71.0211 Boehringer Ingelheim Investigational Site

Birmingham, Alabama, United States

Site Status

1160.71.0115 Boehringer Ingelheim Investigational Site

Mobile, Alabama, United States

Site Status

1160.71.0104 Boehringer Ingelheim Investigational Site

Lake Havasu City, Arizona, United States

Site Status

1160.71.0185 Boehringer Ingelheim Investigational Site

Tucson, Arizona, United States

Site Status

1160.71.0038 Boehringer Ingelheim Investigational Site

Hot Springs, Arkansas, United States

Site Status

1160.71.0302 Boehringer Ingelheim Investigational Site

Jonesboro, Arkansas, United States

Site Status

1160.71.0191 Boehringer Ingelheim Investigational Site

Little Rock, Arkansas, United States

Site Status

1160.71.0213 Boehringer Ingelheim Investigational Site

Little Rock, Arkansas, United States

Site Status

1160.71.0441 Boehringer Ingelheim Investigational Site

Carmichael, California, United States

Site Status

1160.71.0333 Boehringer Ingelheim Investigational Site

Fullerton, California, United States

Site Status

1160.71.0384 Boehringer Ingelheim Investigational Site

La Jolla, California, United States

Site Status

1160.71.0246 Boehringer Ingelheim Investigational Site

Lancaster, California, United States

Site Status

1160.71.0070 Boehringer Ingelheim Investigational Site

Merced, California, United States

Site Status

1160.71.0349 Boehringer Ingelheim Investigational Site

Oakland, California, United States

Site Status

1160.71.0016 Boehringer Ingelheim Investigational Site

Oceanside, California, United States

Site Status

1160.71.0459 Boehringer Ingelheim Investigational Site

Pasadena, California, United States

Site Status

1160.71.0270 Boehringer Ingelheim Investigational Site

Poway, California, United States

Site Status

1160.71.0135 Boehringer Ingelheim Investigational Site

Riverside, California, United States

Site Status

1160.71.0300 Boehringer Ingelheim Investigational Site

Sacramento, California, United States

Site Status

1160.71.0284 Boehringer Ingelheim Investigational Site

San Diego, California, United States

Site Status

1160.71.0379 Boehringer Ingelheim Investigational Site

Walnut Creek, California, United States

Site Status

1160.71.0321 Boehringer Ingelheim Investigational Site

Colorado Springs, Colorado, United States

Site Status

1160.71.0449 Boehringer Ingelheim Investigational Site

Colorado Springs, Colorado, United States

Site Status

1160.71.0360 Boehringer Ingelheim Investigational Site

Denver, Colorado, United States

Site Status

1160.71.0413 Boehringer Ingelheim Investigational Site

Denver, Colorado, United States

Site Status

1160.71.0362 Boehringer Ingelheim Investigational Site

Fort Collins, Colorado, United States

Site Status

1160.71.0278 Boehringer Ingelheim Investigational Site

Bridgeport, Connecticut, United States

Site Status

1160.71.0482 Boehringer Ingelheim Investigational Site

Guilford, Connecticut, United States

Site Status

1160.71.0382 Boehringer Ingelheim Investigational Site

Boynton Beach, Florida, United States

Site Status

1160.71.0056 Boehringer Ingelheim Investigational Site

Brandon, Florida, United States

Site Status

1160.71.0296 Boehringer Ingelheim Investigational Site

Clearwater, Florida, United States

Site Status

1160.71.0327 Boehringer Ingelheim Investigational Site

Coral Springs, Florida, United States

Site Status

1160.71.0376 Boehringer Ingelheim Investigational Site

Daytona Beach, Florida, United States

Site Status

1160.71.0074 Boehringer Ingelheim Investigational Site

Fort Myers, Florida, United States

Site Status

1160.71.0089 Boehringer Ingelheim Investigational Site

Jacksonville, Florida, United States

Site Status

1160.71.0232 Boehringer Ingelheim Investigational Site

Jacksonville, Florida, United States

Site Status

1160.71.0427 Boehringer Ingelheim Investigational Site

Jacksonville, Florida, United States

Site Status

1160.71.0012 Boehringer Ingelheim Investigational Site

Lakeland, Florida, United States

Site Status

1160.71.0034 Boehringer Ingelheim Investigational Site

Miami, Florida, United States

Site Status

1160.71.0227 Boehringer Ingelheim Investigational Site

Orlando, Florida, United States

Site Status

1160.71.0095 Boehringer Ingelheim Investigational Site

Ormond Beach, Florida, United States

Site Status

1160.71.0037 Boehringer Ingelheim Investigational Site

Pensacola, Florida, United States

Site Status

1160.71.0137 Boehringer Ingelheim Investigational Site

Port Charlotte, Florida, United States

Site Status

1160.71.0417 Boehringer Ingelheim Investigational Site

Port Charlotte, Florida, United States

Site Status

1160.71.0332 Boehringer Ingelheim Investigational Site

Rockledge, Florida, United States

Site Status

1160.71.0385 Boehringer Ingelheim Investigational Site

Sarasota, Florida, United States

Site Status

1160.71.0015 Boehringer Ingelheim Investigational Site

St. Petersburg, Florida, United States

Site Status

1160.71.0339 Boehringer Ingelheim Investigational Site

St. Petersburg, Florida, United States

Site Status

1160.71.0019 Boehringer Ingelheim Investigational Site

Vero Beach, Florida, United States

Site Status

1160.71.0159 Boehringer Ingelheim Investigational Site

Atlanta, Georgia, United States

Site Status

1160.71.0021 Boehringer Ingelheim Investigational Site

Augusta, Georgia, United States

Site Status

1160.71.0161 Boehringer Ingelheim Investigational Site

Conyers, Georgia, United States

Site Status

1160.71.0218 Boehringer Ingelheim Investigational Site

Cicero, Illinois, United States

Site Status

1160.71.0438 Boehringer Ingelheim Investigational Site

Maywood, Illinois, United States

Site Status

1160.71.0331 Boehringer Ingelheim Investigational Site

Melrose Park, Illinois, United States

Site Status

1160.71.0364 Boehringer Ingelheim Investigational Site

Normal, Illinois, United States

Site Status

1160.71.0109 Boehringer Ingelheim Investigational Site

North Chicago, Illinois, United States

Site Status

1160.71.0152 Boehringer Ingelheim Investigational Site

Oak Lawn, Illinois, United States

Site Status

1160.71.0198 Boehringer Ingelheim Investigational Site

Rockford, Illinois, United States

Site Status

1160.71.0433 Boehringer Ingelheim Investigational Site

Winfield, Illinois, United States

Site Status

1160.71.0377 Boehringer Ingelheim Investigational Site

Fort Wayne, Indiana, United States

Site Status

1160.71.0288 Boehringer Ingelheim Investigational Site

Indianapolis, Indiana, United States

Site Status

1160.71.0352 Boehringer Ingelheim Investigational Site

Indianapolis, Indiana, United States

Site Status

1160.71.0436 Boehringer Ingelheim Investigational Site

Indianapolis, Indiana, United States

Site Status

1160.71.0235 Boehringer Ingelheim Investigational Site

South Bend, Indiana, United States

Site Status

1160.71.0268 Boehringer Ingelheim Investigational Site

Dubuque, Iowa, United States

Site Status

1160.71.0001 Boehringer Ingelheim Investigational Site

West Des Moines, Iowa, United States

Site Status

1160.71.0357 Boehringer Ingelheim Investigational Site

West Des Moines, Iowa, United States

Site Status

1160.71.0422 Boehringer Ingelheim Investigational Site

Lexington, Kentucky, United States

Site Status

1160.71.0178 Boehringer Ingelheim Investigational Site

Louisville, Kentucky, United States

Site Status

1160.71.0397 Boehringer Ingelheim Investigational Site

Louisville, Kentucky, United States

Site Status

1160.71.0310 Boehringer Ingelheim Investigational Site

Owensboro, Kentucky, United States

Site Status

1160.71.0144 Boehringer Ingelheim Investigational Site

Baton Rouge, Louisiana, United States

Site Status

1160.71.0018 Boehringer Ingelheim Investigational Site

Lafayette, Louisiana, United States

Site Status

1160.71.0132 Boehringer Ingelheim Investigational Site

New Iberia, Louisiana, United States

Site Status

1160.71.0096 Boehringer Ingelheim Investigational Site

Auburn, Maine, United States

Site Status

1160.71.0114 Boehringer Ingelheim Investigational Site

Annapolis, Maryland, United States

Site Status

1160.71.0023 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

Site Status

1160.71.0047 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

Site Status

1160.71.0079 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

Site Status

1160.71.0186 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

Site Status

1160.71.0194 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

Site Status

1160.71.0255 Boehringer Ingelheim Investigational Site

Bel Air, Maryland, United States

Site Status

1160.71.0398 Boehringer Ingelheim Investigational Site

Columbia, Maryland, United States

Site Status

1160.71.0177 Boehringer Ingelheim Investigational Site

Rockville, Maryland, United States

Site Status

1160.71.0073 Boehringer Ingelheim Investigational Site

Salisbury, Maryland, United States

Site Status

1160.71.0207 Boehringer Ingelheim Investigational Site

Salisbury, Maryland, United States

Site Status

1160.71.0196 Boehringer Ingelheim Investigational Site

Takoma Park, Maryland, United States

Site Status

1160.71.0187 Boehringer Ingelheim Investigational Site

Towson, Maryland, United States

Site Status

1160.71.0052 Boehringer Ingelheim Investigational Site

Westminster, Maryland, United States

Site Status

1160.71.0443 Boehringer Ingelheim Investigational Site

Haverhill, Massachusetts, United States

Site Status

1160.71.0452 Boehringer Ingelheim Investigational Site

Haverhill, Massachusetts, United States

Site Status

1160.71.0029 Boehringer Ingelheim Investigational Site

Natick, Massachusetts, United States

Site Status

1160.71.0003 Boehringer Ingelheim Investigational Site

North Dartmouth, Massachusetts, United States

Site Status

1160.71.0308 Boehringer Ingelheim Investigational Site

Worcester, Massachusetts, United States

Site Status

1160.71.0154 Boehringer Ingelheim Investigational Site

Grand Blanc, Michigan, United States

Site Status

1160.71.0205 Boehringer Ingelheim Investigational Site

Lapeer, Michigan, United States

Site Status

1160.71.0279 Boehringer Ingelheim Investigational Site

Muskegon, Michigan, United States

Site Status

1160.71.0445 Boehringer Ingelheim Investigational Site

Petoskey, Michigan, United States

Site Status

1160.71.0274 Boehringer Ingelheim Investigational Site

Rochester Hills, Michigan, United States

Site Status

1160.71.0165 Boehringer Ingelheim Investigational Site

Saginaw, Michigan, United States

Site Status

1160.71.0020 Boehringer Ingelheim Investigational Site

Troy, Michigan, United States

Site Status

1160.71.0188 Boehringer Ingelheim Investigational Site

Ypsilanti, Michigan, United States

Site Status

1160.71.0202 Boehringer Ingelheim Investigational Site

Minneapolis, Minnesota, United States

Site Status

1160.71.0101 Boehringer Ingelheim Investigational Site

Saint Paul, Minnesota, United States

Site Status

1160.71.0086 Boehringer Ingelheim Investigational Site

Gulfport, Mississippi, United States

Site Status

1160.71.0119 Boehringer Ingelheim Investigational Site

Tupelo, Mississippi, United States

Site Status

1160.71.0055 Boehringer Ingelheim Investigational Site

Columbia, Missouri, United States

Site Status

1160.71.0257 Boehringer Ingelheim Investigational Site

Kansas City, Missouri, United States

Site Status

1160.71.0336 Boehringer Ingelheim Investigational Site

Saint Charles, Missouri, United States

Site Status

1160.71.0249 Boehringer Ingelheim Investigational Site

St Louis, Missouri, United States

Site Status

1160.71.0027 Boehringer Ingelheim Investigational Site

Kalispell, Montana, United States

Site Status

1160.71.0110 Boehringer Ingelheim Investigational Site

Omaha, Nebraska, United States

Site Status

1160.71.0346 Boehringer Ingelheim Investigational Site

Henderson, Nevada, United States

Site Status

1160.71.0430 Boehringer Ingelheim Investigational Site

Las Vegas, Nevada, United States

Site Status

1160.71.0142 Boehringer Ingelheim Investigational Site

Browns Mills, New Jersey, United States

Site Status

1160.71.0221 Boehringer Ingelheim Investigational Site

Cherry Hill, New Jersey, United States

Site Status

1160.71.0248 Boehringer Ingelheim Investigational Site

Flemington, New Jersey, United States

Site Status

1160.71.0478 Boehringer Ingelheim Investigational Site

Oakland, New Jersey, United States

Site Status

1160.71.0392 Boehringer Ingelheim Investigational Site

Ocean City, New Jersey, United States

Site Status

1160.71.0254 Boehringer Ingelheim Investigational Site

Westwood, New Jersey, United States

Site Status

1160.71.0472 Boehringer Ingelheim Investigational Site

Woodland Park, New Jersey, United States

Site Status

1160.71.0476 Boehringer Ingelheim Investigational Site

Albany, New York, United States

Site Status

1160.71.0044 Boehringer Ingelheim Investigational Site

Cortlandt Manor, New York, United States

Site Status

1160.71.0229 Boehringer Ingelheim Investigational Site

Mineola, New York, United States

Site Status

1160.71.0451 Boehringer Ingelheim Investigational Site

Mineola, New York, United States

Site Status

1160.71.0183 Boehringer Ingelheim Investigational Site

New Rochelle, New York, United States

Site Status

1160.71.0210 Boehringer Ingelheim Investigational Site

Northport, New York, United States

Site Status

1160.71.0075 Boehringer Ingelheim Investigational Site

Poughkeepsie, New York, United States

Site Status

1160.71.0113 Boehringer Ingelheim Investigational Site

The Bronx, New York, United States

Site Status

1160.71.0281 Boehringer Ingelheim Investigational Site

The Bronx, New York, United States

Site Status

1160.71.0414 Boehringer Ingelheim Investigational Site

Troy, New York, United States

Site Status

1160.71.0356 Boehringer Ingelheim Investigational Site

Watertown, New York, United States

Site Status

1160.71.0064 Boehringer Ingelheim Investigational Site

Yonkers, New York, United States

Site Status

1160.71.0353 Boehringer Ingelheim Investigational Site

Asheville, North Carolina, United States

Site Status

1160.71.0080 Boehringer Ingelheim Investigational Site

Charlotte, North Carolina, United States

Site Status

1160.71.0350 Boehringer Ingelheim Investigational Site

Gastonia, North Carolina, United States

Site Status

1160.71.0173 Boehringer Ingelheim Investigational Site

High Point, North Carolina, United States

Site Status

1160.71.0006 Boehringer Ingelheim Investigational Site

Pinehurst, North Carolina, United States

Site Status

1160.71.0002 Boehringer Ingelheim Investigational Site

Statesville, North Carolina, United States

Site Status

1160.71.0069 Boehringer Ingelheim Investigational Site

Statesville, North Carolina, United States

Site Status

1160.71.0102 Boehringer Ingelheim Investigational Site

Grand Forks, North Dakota, United States

Site Status

1160.71.0222 Boehringer Ingelheim Investigational Site

Jamestown, North Dakota, United States

Site Status

1160.71.0203 Boehringer Ingelheim Investigational Site

Akron, Ohio, United States

Site Status

1160.71.0434 Boehringer Ingelheim Investigational Site

Canal Fulton, Ohio, United States

Site Status

1160.71.0402 Boehringer Ingelheim Investigational Site

Cincinnati, Ohio, United States

Site Status

1160.71.0426 Boehringer Ingelheim Investigational Site

Cincinnati, Ohio, United States

Site Status

1160.71.0479 Boehringer Ingelheim Investigational Site

Cincinnati, Ohio, United States

Site Status

1160.71.0263 Boehringer Ingelheim Investigational Site

Cleveland, Ohio, United States

Site Status

1160.71.0480 Boehringer Ingelheim Investigational Site

Cleveland, Ohio, United States

Site Status

1160.71.0267 Boehringer Ingelheim Investigational Site

Columbus, Ohio, United States

Site Status

1160.71.0035 Boehringer Ingelheim Investigational Site

Dayton, Ohio, United States

Site Status

1160.71.0150 Boehringer Ingelheim Investigational Site

Fairview Park, Ohio, United States

Site Status

1160.71.0201 Boehringer Ingelheim Investigational Site

Kettering, Ohio, United States

Site Status

1160.71.0223 Boehringer Ingelheim Investigational Site

Lorain, Ohio, United States

Site Status

1160.71.0214 Boehringer Ingelheim Investigational Site

Lyndhurst, Ohio, United States

Site Status

1160.71.0275 Boehringer Ingelheim Investigational Site

Sandusky, Ohio, United States

Site Status

1160.71.0103 Boehringer Ingelheim Investigational Site

Westlake, Ohio, United States

Site Status

1160.71.0435 Boehringer Ingelheim Investigational Site

Tulsa, Oklahoma, United States

Site Status

1160.71.0139 Boehringer Ingelheim Investigational Site

Corvallis, Oregon, United States

Site Status

1160.71.0325 Boehringer Ingelheim Investigational Site

Eugene, Oregon, United States

Site Status

1160.71.0133 Boehringer Ingelheim Investigational Site

Springfield, Oregon, United States

Site Status

1160.71.0301 Boehringer Ingelheim Investigational Site

Allentown, Pennsylvania, United States

Site Status

1160.71.0295 Boehringer Ingelheim Investigational Site

Camp Hill, Pennsylvania, United States

Site Status

1160.71.0294 Boehringer Ingelheim Investigational Site

Hershey, Pennsylvania, United States

Site Status

1160.71.0369 Boehringer Ingelheim Investigational Site

Jenkintown, Pennsylvania, United States

Site Status

1160.71.0431 Boehringer Ingelheim Investigational Site

Lancaster, Pennsylvania, United States

Site Status

1160.71.0168 Boehringer Ingelheim Investigational Site

Langhorne, Pennsylvania, United States

Site Status

1160.71.0293 Boehringer Ingelheim Investigational Site

Meadowbrook, Pennsylvania, United States

Site Status

1160.71.0394 Boehringer Ingelheim Investigational Site

Norristown, Pennsylvania, United States

Site Status

1160.71.0466 Boehringer Ingelheim Investigational Site

Pittsburgh, Pennsylvania, United States

Site Status

1160.71.0208 Boehringer Ingelheim Investigational Site

Sellersville, Pennsylvania, United States

Site Status

1160.71.1583 Boehringer Ingelheim Investigational Site

Seoul, , South Korea

Site Status

1160.71.0465 Boehringer Ingelheim Investigational Site

Uniontown, Pennsylvania, United States

Site Status

1160.71.0032 Boehringer Ingelheim Investigational Site

Wynnewood, Pennsylvania, United States

Site Status

1160.71.0067 Boehringer Ingelheim Investigational Site

Wyomissing, Pennsylvania, United States

Site Status

1160.71.0007 Boehringer Ingelheim Investigational Site

Beaufort, South Carolina, United States

Site Status

1160.71.0383 Boehringer Ingelheim Investigational Site

Charleston, South Carolina, United States

Site Status

1160.71.0313 Boehringer Ingelheim Investigational Site

Greenville, South Carolina, United States

Site Status

1160.71.0166 Boehringer Ingelheim Investigational Site

Spartanburg, South Carolina, United States

Site Status

1160.71.0008 Boehringer Ingelheim Investigational Site

Summerville, South Carolina, United States

Site Status

1160.71.0084 Boehringer Ingelheim Investigational Site

Chattanooga, Tennessee, United States

Site Status

1160.71.0474 Boehringer Ingelheim Investigational Site

Clinton, Tennessee, United States

Site Status

1160.71.0062 Boehringer Ingelheim Investigational Site

Germantown, Tennessee, United States

Site Status

1160.71.0370 Boehringer Ingelheim Investigational Site

Johnson City, Tennessee, United States

Site Status

1160.71.0395 Boehringer Ingelheim Investigational Site

Nashville, Tennessee, United States

Site Status

1160.71.0129 Boehringer Ingelheim Investigational Site

Austin, Texas, United States

Site Status

1160.71.0410 Boehringer Ingelheim Investigational Site

Austin, Texas, United States

Site Status

1160.71.0156 Boehringer Ingelheim Investigational Site

Dallas, Texas, United States

Site Status

1160.71.0315 Boehringer Ingelheim Investigational Site

Fort Worth, Texas, United States

Site Status

1160.71.1589 Boehringer Ingelheim Investigational Site

Seoul, , South Korea

Site Status

1160.71.0447 Boehringer Ingelheim Investigational Site

Houston, Texas, United States

Site Status

1160.71.0483 Boehringer Ingelheim Investigational Site

Killeen, Texas, United States

Site Status

1160.71.0335 Boehringer Ingelheim Investigational Site

Lubbock, Texas, United States

Site Status

1160.71.0269 Boehringer Ingelheim Investigational Site

San Antonio, Texas, United States

Site Status

1160.71.0307 Boehringer Ingelheim Investigational Site

San Antonio, Texas, United States

Site Status

1160.71.0285 Boehringer Ingelheim Investigational Site

San Marcos, Texas, United States

Site Status

1160.71.0367 Boehringer Ingelheim Investigational Site

Tyler, Texas, United States

Site Status

1160.71.0453 Boehringer Ingelheim Investigational Site

Charlottesville, Virginia, United States

Site Status

1160.71.0053 Boehringer Ingelheim Investigational Site

Chesapeake, Virginia, United States

Site Status

1160.71.0428 Boehringer Ingelheim Investigational Site

Fredericksburg, Virginia, United States

Site Status

1160.71.0311 Boehringer Ingelheim Investigational Site

Harrisonburg, Virginia, United States

Site Status

1160.71.0292 Boehringer Ingelheim Investigational Site

Newport News, Virginia, United States

Site Status

1160.71.0220 Boehringer Ingelheim Investigational Site

Salem, Virginia, United States

Site Status

1160.71.0224 Boehringer Ingelheim Investigational Site

Suffolk, Virginia, United States

Site Status

1160.71.0317 Boehringer Ingelheim Investigational Site

Winchester, Virginia, United States

Site Status

1160.71.0050 Boehringer Ingelheim Investigational Site

Bellingham, Washington, United States

Site Status

1160.71.0040 Boehringer Ingelheim Investigational Site

Burien, Washington, United States

Site Status

1160.71.0250 Boehringer Ingelheim Investigational Site

Spokane, Washington, United States

Site Status

1160.71.0256 Boehringer Ingelheim Investigational Site

Tacoma, Washington, United States

Site Status

1160.71.0024 Boehringer Ingelheim Investigational Site

Wenatchee, Washington, United States

Site Status

1160.71.0169 Boehringer Ingelheim Investigational Site

Clarksburg, West Virginia, United States

Site Status

1160.71.0365 Boehringer Ingelheim Investigational Site

Huntington, West Virginia, United States

Site Status

1160.71.0099 Boehringer Ingelheim Investigational Site

Madison, Wisconsin, United States

Site Status

1160.71.0072 Boehringer Ingelheim Investigational Site

Milwaukee, Wisconsin, United States

Site Status

1160.71.0461 Boehringer Ingelheim Investigational Site

Milwaukee, Wisconsin, United States

Site Status

1160.71.0508 Boehringer Ingelheim Investigational Site

Coffs Harbour, New South Wales, Australia

Site Status

1160.71.0510 Boehringer Ingelheim Investigational Site

Gosford, New South Wales, Australia

Site Status

1160.71.0506 Boehringer Ingelheim Investigational Site

Milton, Queensland, Australia

Site Status

1160.71.0509 Boehringer Ingelheim Investigational Site

Ashford, South Australia, Australia

Site Status

1160.71.0507 Boehringer Ingelheim Investigational Site

Launceston, Tasmania, Australia

Site Status

1160.71.0504 Boehringer Ingelheim Investigational Site

Box Hill, Victoria, Australia

Site Status

1160.71.0501 Boehringer Ingelheim Investigational Site

Geelong, Victoria, Australia

Site Status

1160.71.0543 Boehringer Ingelheim Investigational Site

Graz, , Austria

Site Status

1160.71.0549 Boehringer Ingelheim Investigational Site

Linz, , Austria

Site Status

1160.71.0541 Boehringer Ingelheim Investigational Site

Vienna, , Austria

Site Status

1160.71.0542 Boehringer Ingelheim Investigational Site

Vienna, , Austria

Site Status

1160.71.0545 Boehringer Ingelheim Investigational Site

Vienna, , Austria

Site Status

1160.71.0547 Boehringer Ingelheim Investigational Site

Vienna, , Austria

Site Status

1160.71.0548 Boehringer Ingelheim Investigational Site

Vienna, , Austria

Site Status

1160.71.0550 Boehringer Ingelheim Investigational Site

Wiener Neustadt, , Austria

Site Status

1160.71.0564 Boehringer Ingelheim Investigational Site

Aalst, , Belgium

Site Status

1160.71.0572 Boehringer Ingelheim Investigational Site

Brasschaat, , Belgium

Site Status

1160.71.0571 Boehringer Ingelheim Investigational Site

Brussels, , Belgium

Site Status

1160.71.0581 Boehringer Ingelheim Investigational Site

Brussels, , Belgium

Site Status

1160.71.0585 Boehringer Ingelheim Investigational Site

Brussels, , Belgium

Site Status

1160.71.0563 Boehringer Ingelheim Investigational Site

Edegem, , Belgium

Site Status

1160.71.0578 Boehringer Ingelheim Investigational Site

Genk, , Belgium

Site Status

1160.71.0587 Boehringer Ingelheim Investigational Site

Genk, , Belgium

Site Status

1160.71.0574 Boehringer Ingelheim Investigational Site

Ghent, , Belgium

Site Status

1160.71.0588 Boehringer Ingelheim Investigational Site

Gilly, , Belgium

Site Status

1160.71.0568 Boehringer Ingelheim Investigational Site

Hasselt, , Belgium

Site Status

1160.71.0561 Boehringer Ingelheim Investigational Site

Leuven, , Belgium

Site Status

1160.71.0579 Boehringer Ingelheim Investigational Site

Liège, , Belgium

Site Status

1160.71.0567 Boehringer Ingelheim Investigational Site

Ostend, , Belgium

Site Status

1160.71.0570 Boehringer Ingelheim Investigational Site

Roeselare, , Belgium

Site Status

1160.71.0566 Boehringer Ingelheim Investigational Site

Tienen, , Belgium

Site Status

1160.71.0562 Boehringer Ingelheim Investigational Site

Turnhout, , Belgium

Site Status

1160.71.0644 Boehringer Ingelheim Investigational Site

Campinas, , Brazil

Site Status

1160.71.0650 Boehringer Ingelheim Investigational Site

Curitiba, , Brazil

Site Status

1160.71.0651 Boehringer Ingelheim Investigational Site

Curitiba, , Brazil

Site Status

1160.71.0652 Boehringer Ingelheim Investigational Site

Goiânia, , Brazil

Site Status

1160.71.0646 Boehringer Ingelheim Investigational Site

Sao Jose Do Riio Preto, , Brazil

Site Status

1160.71.0647 Boehringer Ingelheim Investigational Site

São José do Rio Preto, , Brazil

Site Status

1160.71.0643 Boehringer Ingelheim Investigational Site

São Paulo, , Brazil

Site Status

1160.71.0620 Boehringer Ingelheim Investigational Site

Pleven, , Bulgaria

Site Status

1160.71.0611 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0612 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0615 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0617 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0618 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0625 Boehringer Ingelheim Investigational Site

Sofia, , Bulgaria

Site Status

1160.71.0694 Boehringer Ingelheim Investigational Site

Calgary, Alberta, Canada

Site Status

1160.71.0696 Boehringer Ingelheim Investigational Site

Calgary, Alberta, Canada

Site Status

1160.71.0680 Boehringer Ingelheim Investigational Site

Coquitlam, British Columbia, Canada

Site Status

1160.71.0712 Boehringer Ingelheim Investigational Site

Coquitlam, British Columbia, Canada

Site Status

1160.71.0706 Boehringer Ingelheim Investigational Site

Kelowna, British Columbia, Canada

Site Status

1160.71.0725 Boehringer Ingelheim Investigational Site

Nanaimo, British Columbia, Canada

Site Status

1160.71.0691 Boehringer Ingelheim Investigational Site

New Westminster, British Columbia, Canada

Site Status

1160.71.0714 Boehringer Ingelheim Investigational Site

Victoria, British Columbia, Canada

Site Status

1160.71.0701 Boehringer Ingelheim Investigational Site

Portage la Prairie, Manitoba, Canada

Site Status

1160.71.0703 Boehringer Ingelheim Investigational Site

Halifax, Nova Scotia, Canada

Site Status

1160.71.0674 Boehringer Ingelheim Investigational Site

Burlington, Ontario, Canada

Site Status

1160.71.0702 Boehringer Ingelheim Investigational Site

Cambridge, Ontario, Canada

Site Status

1160.71.0720 Boehringer Ingelheim Investigational Site

Cambridge, Ontario, Canada

Site Status

1160.71.0715 Boehringer Ingelheim Investigational Site

Greater Sudbury, Ontario, Canada

Site Status

1160.71.0692 Boehringer Ingelheim Investigational Site

Grimsby, Ontario, Canada

Site Status

1160.71.0697 Boehringer Ingelheim Investigational Site

Hamilton, Ontario, Canada

Site Status

1160.71.0710 Boehringer Ingelheim Investigational Site

Hamilton, Ontario, Canada

Site Status

1160.71.0719 Boehringer Ingelheim Investigational Site

Hamilton, Ontario, Canada

Site Status

1160.71.0721 Boehringer Ingelheim Investigational Site

Hamilton, Ontario, Canada

Site Status

1160.71.0708 Boehringer Ingelheim Investigational Site

Mississauga, Ontario, Canada

Site Status

1160.71.0688 Boehringer Ingelheim Investigational Site

Newmarket, Ontario, Canada

Site Status

1160.71.0672 Boehringer Ingelheim Investigational Site

Oshawa, Ontario, Canada

Site Status

1160.71.0687 Boehringer Ingelheim Investigational Site

Ottawa, Ontario, Canada

Site Status

1160.71.0679 Boehringer Ingelheim Investigational Site

Scarborough Village, Ontario, Canada

Site Status

1160.71.0723 Boehringer Ingelheim Investigational Site

Scarborough Village, Ontario, Canada

Site Status

1160.71.0690 Boehringer Ingelheim Investigational Site

Thunder Bay, Ontario, Canada

Site Status

1160.71.0684 Boehringer Ingelheim Investigational Site

Toronto, Ontario, Canada

Site Status

1160.71.0718 Boehringer Ingelheim Investigational Site

Toronto, Ontario, Canada

Site Status

1160.71.0686 Boehringer Ingelheim Investigational Site

Windsor, Ontario, Canada

Site Status

1160.71.0683 Boehringer Ingelheim Investigational Site

Montreal, Quebec, Canada

Site Status

1160.71.0705 Boehringer Ingelheim Investigational Site

Montreal, Quebec, Canada

Site Status

1160.71.0709 Boehringer Ingelheim Investigational Site

Montreal, Quebec, Canada

Site Status

1160.71.0716 Boehringer Ingelheim Investigational Site

Montreal, Quebec, Canada

Site Status

1160.71.0700 Boehringer Ingelheim Investigational Site

Québec, Quebec, Canada

Site Status

1160.71.0717 Boehringer Ingelheim Investigational Site

Québec, Quebec, Canada

Site Status

1160.71.0713 Boehringer Ingelheim Investigational Site

Saint George-de-Beauce, Quebec, Canada

Site Status

1160.71.0699 Boehringer Ingelheim Investigational Site

Saint-Charles-Borromée, Quebec, Canada

Site Status

1160.71.0675 Boehringer Ingelheim Investigational Site

Saint-Hyacinthe, Quebec, Canada

Site Status

1160.71.0673 Boehringer Ingelheim Investigational Site

Saskatoon, Saskatchewan, Canada

Site Status

1160.71.0678 Boehringer Ingelheim Investigational Site

Saskatoon, Saskatchewan, Canada

Site Status

1160.71.0771 Boehringer Ingelheim Investigational Site

Beijing, , China

Site Status

1160.71.0772 Boehringer Ingelheim Investigational Site

Beijing, , China

Site Status

1160.71.0773 Boehringer Ingelheim Investigational Site

Beijing, , China

Site Status

1160.71.0774 Boehringer Ingelheim Investigational Site

Beijing, , China

Site Status

1160.71.0776 Boehringer Ingelheim Investigational Site

Haerbin, , China

Site Status

1160.71.0784 Boehringer Ingelheim Investigational Site

Hangzhou, , China

Site Status

1160.71.0778 Boehringer Ingelheim Investigational Site

Qingdao, , China

Site Status

1160.71.0781 Boehringer Ingelheim Investigational Site

Shanghai, , China

Site Status

1160.71.0782 Boehringer Ingelheim Investigational Site

Shanghai, , China

Site Status

1160.71.0777 Boehringer Ingelheim Investigational Site

Shenyang, , China

Site Status

1160.71.0780 Boehringer Ingelheim Investigational Site

Shijiazhuang, , China

Site Status

1160.71.0816 Boehringer Ingelheim Investigational Site

Modřice, , Czechia

Site Status

1160.71.0820 Boehringer Ingelheim Investigational Site

Ostrava, , Czechia

Site Status

1160.71.0818 Boehringer Ingelheim Investigational Site

Pardubice, , Czechia

Site Status

1160.71.0814 Boehringer Ingelheim Investigational Site

Plzen-Bory, , Czechia

Site Status

1160.71.0811 Boehringer Ingelheim Investigational Site

Prague, , Czechia

Site Status

1160.71.0812 Boehringer Ingelheim Investigational Site

Prague, , Czechia

Site Status

1160.71.0813 Boehringer Ingelheim Investigational Site

Prague, , Czechia

Site Status

1160.71.0817 Boehringer Ingelheim Investigational Site

Příbram, , Czechia

Site Status

1160.71.0819 Boehringer Ingelheim Investigational Site

Ústí nad Orlicí, , Czechia

Site Status

1160.71.0837 Boehringer Ingelheim Investigational Site

Aalborg, , Denmark

Site Status

1160.71.0835 Boehringer Ingelheim Investigational Site

Aarhus C, , Denmark

Site Status

1160.71.0833 Boehringer Ingelheim Investigational Site

Elsinore, , Denmark

Site Status

1160.71.0838 Boehringer Ingelheim Investigational Site

Frederikssund, , Denmark

Site Status

1160.71.0834 Boehringer Ingelheim Investigational Site

Herlev, , Denmark

Site Status

1160.71.0841 Boehringer Ingelheim Investigational Site

Horsens, , Denmark

Site Status

1160.71.0832 Boehringer Ingelheim Investigational Site

Hvidovre, , Denmark

Site Status

1160.71.0840 Boehringer Ingelheim Investigational Site

Køge, , Denmark

Site Status

1160.71.0831 Boehringer Ingelheim Investigational Site

Odense, , Denmark

Site Status

1160.71.0839 Boehringer Ingelheim Investigational Site

Roskilde, , Denmark

Site Status

1160.71.0836 Boehringer Ingelheim Investigational Site

Svendborg, , Denmark

Site Status

1160.71.0851 Boehringer Ingelheim Investigational Site

Helsinki, , Finland

Site Status

1160.71.0859 Boehringer Ingelheim Investigational Site

Jyväskylä, , Finland

Site Status

1160.71.0854 Boehringer Ingelheim Investigational Site

Oulu, , Finland

Site Status

1160.71.0858 Boehringer Ingelheim Investigational Site

Pori, , Finland

Site Status

1160.71.0852 Boehringer Ingelheim Investigational Site

Tampere, , Finland

Site Status

1160.71.0853 Boehringer Ingelheim Investigational Site

Turku, , Finland

Site Status

1160.71.875A Boehringer Ingelheim Investigational Site

Abbeville, , France

Site Status

1160.71.882D Boehringer Ingelheim Investigational Site

Angers, , France

Site Status

1160.71.882G Boehringer Ingelheim Investigational Site

Angers, , France

Site Status

1160.71.879F Boehringer Ingelheim Investigational Site

Besle Sur Vilaine, , France

Site Status

1160.71.882K Boehringer Ingelheim Investigational Site

Château-Gontier, , France

Site Status

1160.71.887A Boehringer Ingelheim Investigational Site

Cholet, , France

Site Status

1160.71.879C Boehringer Ingelheim Investigational Site

Derval, , France

Site Status

1160.71.882H Boehringer Ingelheim Investigational Site

Feneu, , France

Site Status

1160.71.888A Boehringer Ingelheim Investigational Site

Grenoble Cédex 9, , France

Site Status

1160.71.879B Boehringer Ingelheim Investigational Site

La Chapelle-sur-Erdre, , France

Site Status

1160.71.874A Boehringer Ingelheim Investigational Site

Langres, , France

Site Status

1160.71.884A Boehringer Ingelheim Investigational Site

Laval, , France

Site Status

1160.71.880B Boehringer Ingelheim Investigational Site

Le Mesnil En Valée, , France

Site Status

1160.71.880A Boehringer Ingelheim Investigational Site

Mûrs-Erigné, , France

Site Status

1160.71.879A Boehringer Ingelheim Investigational Site

Nantes, , France

Site Status

1160.71.879H Boehringer Ingelheim Investigational Site

Nantes, , France

Site Status

1160.71.879S Boehringer Ingelheim Investigational Site

Nantes, , France

Site Status

1160.71.880J Boehringer Ingelheim Investigational Site

Parçay-les-Pins, , France

Site Status

1160.71.871A Boehringer Ingelheim Investigational Site

Paris, , France

Site Status

1160.71.879E Boehringer Ingelheim Investigational Site

Saint-Aubin-des-Châteaux, , France

Site Status

1160.71.880D Boehringer Ingelheim Investigational Site

Segré, , France

Site Status

1160.71.882A Boehringer Ingelheim Investigational Site

Tiercé, , France

Site Status

1160.71.882B Boehringer Ingelheim Investigational Site

Tiercé, , France

Site Status

1160.71.882C Boehringer Ingelheim Investigational Site

Tiercé, , France

Site Status

1160.71.879G Boehringer Ingelheim Investigational Site

Vieillevigne, , France

Site Status

1160.71.880E Boehringer Ingelheim Investigational Site

Vihiers, , France

Site Status

1160.71.0932 Boehringer Ingelheim Investigational Site

Berlin, , Germany

Site Status

1160.71.0948 Boehringer Ingelheim Investigational Site

Berlin, , Germany

Site Status

1160.71.0962 Boehringer Ingelheim Investigational Site

Berlin, , Germany

Site Status

1160.71.0940 Boehringer Ingelheim Investigational Site

Bochum, , Germany

Site Status

1160.71.0963 Boehringer Ingelheim Investigational Site

Cologne, , Germany

Site Status

1160.71.0972 Boehringer Ingelheim Investigational Site

Dortmund, , Germany

Site Status

1160.71.0934 Boehringer Ingelheim Investigational Site

Essen, , Germany

Site Status

1160.71.0931 Boehringer Ingelheim Investigational Site

Frankfurt am Main, , Germany

Site Status

1160.71.0943 Boehringer Ingelheim Investigational Site

Heidelberg, , Germany

Site Status

1160.71.0946 Boehringer Ingelheim Investigational Site

Lahr, , Germany

Site Status

1160.71.0944 Boehringer Ingelheim Investigational Site

Limburg, , Germany

Site Status

1160.71.0951 Boehringer Ingelheim Investigational Site

Mainz, , Germany

Site Status

1160.71.0933 Boehringer Ingelheim Investigational Site

Mannheim, , Germany

Site Status

1160.71.0945 Boehringer Ingelheim Investigational Site

Mannheim, , Germany

Site Status

1160.71.0970 Boehringer Ingelheim Investigational Site

Mannheim, , Germany

Site Status

1160.71.0937 Boehringer Ingelheim Investigational Site

Witten, , Germany

Site Status

1160.71.0966 Boehringer Ingelheim Investigational Site

Wuppertal, , Germany

Site Status

1160.71.0901 Boehringer Ingelheim Investigational Site

Athens, , Greece

Site Status

1160.71.0914 Boehringer Ingelheim Investigational Site

Kalamaria-Thessaloniki, , Greece

Site Status

1160.71.0904 Boehringer Ingelheim Investigational Site

Larissa, , Greece

Site Status

1160.71.0910 Boehringer Ingelheim Investigational Site

Thebes, , Greece

Site Status

1160.71.0903 Boehringer Ingelheim Investigational Site

Trikala, , Greece

Site Status

1160.71.0905 Boehringer Ingelheim Investigational Site

Voula - Athens, , Greece

Site Status

1160.71.1003 Boehringer Ingelheim Investigational Site

Kowloon, , Hong Kong

Site Status

1160.71.1004 Boehringer Ingelheim Investigational Site

Kowloon, , Hong Kong

Site Status

1160.71.1011 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1012 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1013 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1014 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1015 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1016 Boehringer Ingelheim Investigational Site

Budapest, , Hungary

Site Status

1160.71.1020 Boehringer Ingelheim Investigational Site

Gyöngyös, , Hungary

Site Status

1160.71.1017 Boehringer Ingelheim Investigational Site

Komárom, , Hungary

Site Status

1160.71.1018 Boehringer Ingelheim Investigational Site

Pécs, , Hungary

Site Status

1160.71.1057 Boehringer Ingelheim Investigational Site

Ahmedabad, , India

Site Status

1160.71.1056 Boehringer Ingelheim Investigational Site

Ahmedabad-52, , India

Site Status

1160.71.1065 Boehringer Ingelheim Investigational Site

Bangalore, , India

Site Status

1160.71.1062 Boehringer Ingelheim Investigational Site

Hyderabad, , India

Site Status

1160.71.1073 Boehringer Ingelheim Investigational Site

Jaipur, Rajasthan, , India

Site Status

1160.71.1067 Boehringer Ingelheim Investigational Site

Kerala, , India

Site Status

1160.71.1068 Boehringer Ingelheim Investigational Site

Kottayam, , India

Site Status

1160.71.1055 Boehringer Ingelheim Investigational Site

Lucknow, Uttar Pradesh, , India

Site Status

1160.71.1051 Boehringer Ingelheim Investigational Site

Ludhiana, , India

Site Status

1160.71.1072 Boehringer Ingelheim Investigational Site

Mysore, , India

Site Status

1160.71.1059 Boehringer Ingelheim Investigational Site

Nagpur-12, , India

Site Status

1160.71.1052 Boehringer Ingelheim Investigational Site

New Delhi, , India

Site Status

1160.71.1070 Boehringer Ingelheim Investigational Site

Pune, Maharashtra, , India

Site Status

1160.71.1110 Boehringer Ingelheim Investigational Site

Afula, , Israel

Site Status

1160.71.1121 Boehringer Ingelheim Investigational Site

Afula, , Israel

Site Status

1160.71.1111 Boehringer Ingelheim Investigational Site

Ashkelon, , Israel

Site Status

1160.71.1117 Boehringer Ingelheim Investigational Site

Giv‘atayim, , Israel

Site Status

1160.71.1112 Boehringer Ingelheim Investigational Site

Hadera, , Israel

Site Status

1160.71.1091 Boehringer Ingelheim Investigational Site

Haifa, , Israel

Site Status

1160.71.1113 Boehringer Ingelheim Investigational Site

Haifa, , Israel

Site Status

1160.71.1114 Boehringer Ingelheim Investigational Site

Haifa, , Israel

Site Status

1160.71.1116 Boehringer Ingelheim Investigational Site

Haifa, , Israel

Site Status

1160.71.1118 Boehringer Ingelheim Investigational Site

Haifa, , Israel

Site Status

1160.71.1105 Boehringer Ingelheim Investigational Site

Holon, , Israel

Site Status

1160.71.1101 Boehringer Ingelheim Investigational Site

Jerusalem, , Israel

Site Status

1160.71.1104 Boehringer Ingelheim Investigational Site

Jerusalem, , Israel

Site Status

1160.71.1106 Boehringer Ingelheim Investigational Site

Jerusalem, , Israel

Site Status

1160.71.1119 Boehringer Ingelheim Investigational Site

Kfar Saba, , Israel

Site Status

1160.71.1096 Boehringer Ingelheim Investigational Site

Petah Tikva, , Israel

Site Status

1160.71.1093 Boehringer Ingelheim Investigational Site

Ramat Gan, , Israel

Site Status

1160.71.1094 Boehringer Ingelheim Investigational Site

Ramat Gan, , Israel

Site Status

1160.71.1095 Boehringer Ingelheim Investigational Site

Ramat Gan, , Israel

Site Status

1160.71.1100 Boehringer Ingelheim Investigational Site

Rehovot, , Israel

Site Status

1160.71.1103 Boehringer Ingelheim Investigational Site

Safed, , Israel

Site Status

1160.71.1107 Boehringer Ingelheim Investigational Site

Tel Aviv, , Israel

Site Status

1160.71.1108 Boehringer Ingelheim Investigational Site

Tel Aviv, , Israel

Site Status

1160.71.1109 Boehringer Ingelheim Investigational Site

Tel Aviv, , Israel

Site Status

1160.71.1120 Boehringer Ingelheim Investigational Site

Tel Aviv, , Israel

Site Status

1160.71.1122 Boehringer Ingelheim Investigational Site

Tel Aviv, , Israel

Site Status

1160.71.1169 Boehringer Ingelheim Investigational Site

Arezzo, , Italy

Site Status

1160.71.1172 Boehringer Ingelheim Investigational Site

Ascoli Piceno, , Italy

Site Status

1160.71.1170 Boehringer Ingelheim Investigational Site

Sassari, , Italy

Site Status

1160.71.1291 Boehringer Ingelheim Investigational Site

Kuala Lumpur, , Malaysia

Site Status

1160.71.1292 Boehringer Ingelheim Investigational Site

Kuala Lumpur, , Malaysia

Site Status

1160.71.1337 Boehringer Ingelheim Investigational Site

's-Hertogenbosch, , Netherlands

Site Status

1160.71.1344 Boehringer Ingelheim Investigational Site

Almelo, , Netherlands

Site Status

1160.71.1331 Boehringer Ingelheim Investigational Site

Amsterdam, , Netherlands

Site Status

1160.71.1336 Boehringer Ingelheim Investigational Site

Apeldoorn, , Netherlands

Site Status

1160.71.1332 Boehringer Ingelheim Investigational Site

Breda, , Netherlands

Site Status

1160.71.1349 Boehringer Ingelheim Investigational Site

Den Helder, , Netherlands

Site Status

1160.71.1345 Boehringer Ingelheim Investigational Site

Deventer, , Netherlands

Site Status

1160.71.1360 Boehringer Ingelheim Investigational Site

Dirksland, , Netherlands

Site Status

1160.71.1340 Boehringer Ingelheim Investigational Site

Ede, , Netherlands

Site Status

1160.71.1358 Boehringer Ingelheim Investigational Site

Eindhoven, , Netherlands

Site Status

1160.71.1338 Boehringer Ingelheim Investigational Site

Enschede, , Netherlands

Site Status

1160.71.1343 Boehringer Ingelheim Investigational Site

Goes, , Netherlands

Site Status

1160.71.1347 Boehringer Ingelheim Investigational Site

Gorinchem, , Netherlands

Site Status

1160.71.1333 Boehringer Ingelheim Investigational Site

Groningen, , Netherlands

Site Status

1160.71.1361 Boehringer Ingelheim Investigational Site

Heerlen, , Netherlands

Site Status

1160.71.1339 Boehringer Ingelheim Investigational Site

Hengelo, , Netherlands

Site Status

1160.71.1346 Boehringer Ingelheim Investigational Site

Hilversum, , Netherlands

Site Status

1160.71.1356 Boehringer Ingelheim Investigational Site

Hoorn, , Netherlands

Site Status

1160.71.1359 Boehringer Ingelheim Investigational Site

Maastricht, , Netherlands

Site Status

1160.71.1341 Boehringer Ingelheim Investigational Site

Meppel, , Netherlands

Site Status

1160.71.1354 Boehringer Ingelheim Investigational Site

Rotterdam, , Netherlands

Site Status

1160.71.1351 Boehringer Ingelheim Investigational Site

Sneek, , Netherlands

Site Status

1160.71.1353 Boehringer Ingelheim Investigational Site

Tiel, , Netherlands

Site Status

1160.71.1352 Boehringer Ingelheim Investigational Site

Tilburg, , Netherlands

Site Status

1160.71.1350 Boehringer Ingelheim Investigational Site

Veldhoven, , Netherlands

Site Status

1160.71.1342 Boehringer Ingelheim Investigational Site

Velp, , Netherlands

Site Status

1160.71.1348 Boehringer Ingelheim Investigational Site

Zwijndrecht, , Netherlands

Site Status

1160.71.1396 Boehringer Ingelheim Investigational Site

Gjøvik, , Norway

Site Status

1160.71.1393 Boehringer Ingelheim Investigational Site

Moss, , Norway

Site Status

1160.71.1395 Boehringer Ingelheim Investigational Site

Nordbyhagen, , Norway

Site Status

1160.71.1391 Boehringer Ingelheim Investigational Site

Oslo, , Norway

Site Status

1160.71.1397 Boehringer Ingelheim Investigational Site

Oslo, , Norway

Site Status

1160.71.1394 Boehringer Ingelheim Investigational Site

Rud, , Norway

Site Status

1160.71.1422 Boehringer Ingelheim Investigational Site

Ermita Manila, , Philippines

Site Status

1160.71.1421 Boehringer Ingelheim Investigational Site

Manila, , Philippines

Site Status

1160.71.1424 Boehringer Ingelheim Investigational Site

Pasig, , Philippines

Site Status

1160.71.1423 Boehringer Ingelheim Investigational Site

Quezon City, , Philippines

Site Status

1160.71.1425 Boehringer Ingelheim Investigational Site

Quezon City, , Philippines

Site Status

1160.71.1436 Boehringer Ingelheim Investigational Site

Gdynia, , Poland

Site Status

1160.71.1437 Boehringer Ingelheim Investigational Site

Gdynia, , Poland

Site Status

1160.71.1438 Boehringer Ingelheim Investigational Site

Gdynia, , Poland

Site Status

1160.71.1433 Boehringer Ingelheim Investigational Site

Puławy, , Poland

Site Status

1160.71.1431 Boehringer Ingelheim Investigational Site

Warsaw, , Poland

Site Status

1160.71.1432 Boehringer Ingelheim Investigational Site

Warsaw, , Poland

Site Status

1160.71.1434 Boehringer Ingelheim Investigational Site

Zabrze, , Poland

Site Status

1160.71.1456 Boehringer Ingelheim Investigational Site

Amadora, , Portugal

Site Status

1160.71.1451 Boehringer Ingelheim Investigational Site

Carnaxide, , Portugal

Site Status

1160.71.1454 Boehringer Ingelheim Investigational Site

Coimbra, , Portugal

Site Status

1160.71.1459 Boehringer Ingelheim Investigational Site

Coimbra, , Portugal

Site Status

1160.71.1457 Boehringer Ingelheim Investigational Site

Covilha, , Portugal

Site Status

1160.71.1455 Boehringer Ingelheim Investigational Site

Porto, , Portugal

Site Status

1160.71.1471 Boehringer Ingelheim Investigational Site

Bucharest, , Romania

Site Status

1160.71.1472 Boehringer Ingelheim Investigational Site

Bucharest, , Romania

Site Status

1160.71.1501 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1503 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1504 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1505 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1507 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1508 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1509 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1510 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1511 Boehringer Ingelheim Investigational Site

Moscow, , Russia

Site Status

1160.71.1512 Boehringer Ingelheim Investigational Site

Saint Petersburg, , Russia

Site Status

1160.71.1513 Boehringer Ingelheim Investigational Site

Saint Petersburg, , Russia

Site Status

1160.71.1514 Boehringer Ingelheim Investigational Site

Saint Petersburg, , Russia

Site Status

1160.71.1531 Boehringer Ingelheim Investigational Site

Singapore, , Singapore

Site Status

1160.71.1548 Boehringer Ingelheim Investigational Site

Banská Bystrica, , Slovakia

Site Status

1160.71.1541 Boehringer Ingelheim Investigational Site

Bratislava, , Slovakia

Site Status

1160.71.1542 Boehringer Ingelheim Investigational Site

Bratislava, , Slovakia

Site Status

1160.71.1543 Boehringer Ingelheim Investigational Site

Bratislava, , Slovakia

Site Status

1160.71.1550 Boehringer Ingelheim Investigational Site

Košice, , Slovakia

Site Status

1160.71.1547 Boehringer Ingelheim Investigational Site

Žilina, , Slovakia

Site Status

1160.71.1585 Boehringer Ingelheim Investigational Site

Busan, , South Korea

Site Status

1160.71.1586 Boehringer Ingelheim Investigational Site

Cheonan-si, , South Korea

Site Status

1160.71.1584 Boehringer Ingelheim Investigational Site

Daegu, , South Korea

Site Status

1160.71.1591 Boehringer Ingelheim Investigational Site

Daegu, , South Korea

Site Status

1160.71.1590 Boehringer Ingelheim Investigational Site

Gwangju, , South Korea

Site Status

1160.71.1581 Boehringer Ingelheim Investigational Site

Incheon, , South Korea

Site Status

1160.71.1592 Boehringer Ingelheim Investigational Site

Seoul, , South Korea

Site Status

1160.71.1593 Boehringer Ingelheim Investigational Site

Seoul, , South Korea

Site Status

1160.71.1633 Boehringer Ingelheim Investigational Site

Gothenburg, , Sweden

Site Status

1160.71.1627 Boehringer Ingelheim Investigational Site

Malmo, , Sweden

Site Status

1160.71.1628 Boehringer Ingelheim Investigational Site

Nässjö, , Sweden

Site Status

1160.71.1625 Boehringer Ingelheim Investigational Site

Norrköping, , Sweden

Site Status

1160.71.1623 Boehringer Ingelheim Investigational Site

Örebro, , Sweden

Site Status

1160.71.1626 Boehringer Ingelheim Investigational Site

Stockholm, , Sweden

Site Status

1160.71.1634 Boehringer Ingelheim Investigational Site

Stockholm, , Sweden

Site Status

1160.71.1624 Boehringer Ingelheim Investigational Site

Umeå, , Sweden

Site Status

1160.71.1621 Boehringer Ingelheim Investigational Site

Uppsala, , Sweden

Site Status

1160.71.1635 Boehringer Ingelheim Investigational Site

Uppsala, , Sweden

Site Status

1160.71.1622 Boehringer Ingelheim Investigational Site

Västerås, , Sweden

Site Status

1160.71.1652 Boehringer Ingelheim Investigational Site

Basel, , Switzerland

Site Status

1160.71.1655 Boehringer Ingelheim Investigational Site

Bellinzona, , Switzerland

Site Status

1160.71.1651 Boehringer Ingelheim Investigational Site

Bern, , Switzerland

Site Status

1160.71.1654 Boehringer Ingelheim Investigational Site

Lugano, , Switzerland

Site Status

1160.71.1680 Boehringer Ingelheim Investigational Site

Changhua, , Taiwan

Site Status

1160.71.1683 Boehringer Ingelheim Investigational Site

Hualien City, , Taiwan

Site Status

1160.71.1682 Boehringer Ingelheim Investigational Site

Kaohsiung City, , Taiwan

Site Status

1160.71.1679 Boehringer Ingelheim Investigational Site

Taichung, , Taiwan

Site Status

1160.71.1681 Boehringer Ingelheim Investigational Site

Tainan City, , Taiwan

Site Status

1160.71.1671 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1672 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1673 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1674 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1675 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1676 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1677 Boehringer Ingelheim Investigational Site

Taipei, , Taiwan

Site Status

1160.71.1678 Boehringer Ingelheim Investigational Site

Taoyuan District, , Taiwan

Site Status

1160.71.1701 Boehringer Ingelheim Investigational Site

Bangkok, , Thailand

Site Status

1160.71.1703 Boehringer Ingelheim Investigational Site

Chiang Mai, , Thailand

Site Status

1160.71.1704 Boehringer Ingelheim Investigational Site

Khon Kaen, , Thailand

Site Status

1160.71.1744 Boehringer Ingelheim Investigational Site

Birmingham, , United Kingdom

Site Status

1160.71.1746 Boehringer Ingelheim Investigational Site

Chertsey, , United Kingdom

Site Status

1160.71.1745 Boehringer Ingelheim Investigational Site

County Armagh, , United Kingdom

Site Status

1160.71.1755 Boehringer Ingelheim Investigational Site

Kirkcaldy, Fife, , United Kingdom

Site Status

1160.71.1741 Boehringer Ingelheim Investigational Site

London, , United Kingdom

Site Status

1160.71.1742 Boehringer Ingelheim Investigational Site

Newcastle upon Tyne, , United Kingdom

Site Status

1160.71.1751 Boehringer Ingelheim Investigational Site

Newport, , United Kingdom

Site Status

1160.71.1752 Boehringer Ingelheim Investigational Site

Northampton, , United Kingdom

Site Status

1160.71.1743 Boehringer Ingelheim Investigational Site

Romford, Essex, , United Kingdom

Site Status

1160.71.1748 Boehringer Ingelheim Investigational Site

York, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Brazil Bulgaria Canada China Czechia Denmark Finland France Germany Greece Hong Kong Hungary India Israel Italy Malaysia Netherlands Norway Philippines Poland Portugal Romania Russia Singapore Slovakia South Korea Sweden Switzerland Taiwan Thailand United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation. 2013 Jul 16;128(3):237-43. doi: 10.1161/CIRCULATIONAHA.112.001139. Epub 2013 Jun 14.

Reference Type DERIVED
PMID: 23770747 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008-005248-17

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

1160.71

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)
NCT00680186 COMPLETED PHASE3
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
NCT00558259 COMPLETED PHASE3
Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
NCT02149303 COMPLETED
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
NCT02164864 COMPLETED PHASE3
Comparative Effectiveness and Safety Between Warfarin and Dabigatran
NCT03254134 COMPLETED
The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
NCT02061748 COMPLETED
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
NCT04297150 UNKNOWN
Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment
NCT01721837 COMPLETED
A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
NCT03792152 UNKNOWN NA
Sequential Expansion of Comparative Effectiveness of Anticoagulants
NCT02081807 COMPLETED
A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants
NCT04208061 COMPLETED PHASE1
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
NCT01976507 COMPLETED PHASE4
Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention
NCT00818753 COMPLETED PHASE2
The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage
NCT02043808 COMPLETED
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
NCT03061006 COMPLETED PHASE4
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment
NCT02182024 COMPLETED PHASE1
Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
NCT02104947 COMPLETED PHASE3
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
NCT04735523 COMPLETED
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
NCT00781391 COMPLETED PHASE3
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
NCT00403767 COMPLETED PHASE3
Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
NCT02256683 TERMINATED PHASE2
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
NCT02942576 COMPLETED PHASE3
Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
NCT02067182 COMPLETED PHASE4
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
NCT00806624 COMPLETED PHASE2
Secondary Prevention of Venous Thrombo Embolism (VTE).
NCT00329238 COMPLETED PHASE3